Clarity Before commitment
Look beyond the numbers. Understand the opportunity.
Important decisions need more than a good story.
Our due diligence service gives investors, acquirers and Life Sciences companies an independent, third-party view of the business, facility, project or opportunity in front of them.
We look at the factors that can affect value, performance and future potential; from operations and technical capability to financial health, market conditions, regulatory risk and people.
Our approach is practical and evidence-led. We ask the questions that matter, identify potential risks and give you a clearer picture before you make a significant decision.
How We’re Different
01
Independent Perspective
We provide an unbiased third-party assessment, giving you another perspective before you commit.
02
We Understand the Industry
Our hands-on experience across Life Sciences, engineering, manufacturing, CQV and major CAPEX programmes helps us understand what we are assessing.
03
Practical, Not Theoretical
We focus on what findings could mean for the business, its operations and its future.
04
Technical & Commercial
We bring together technical, operational and commercial considerations rather than looking at one area in isolation.
05
We Follow the Evidence
We examine available data, performance indicators, market information and operational records to test the assumptions behind a deal.
06
Proportionate to the Decision
Every transaction is different. We can focus on specific risk areas or provide a broader assessment depending on what you need to understand.
Who This is For
Whether you are assessing a company, facility, project or potential investment, we help you understand what sits beneath the headline opportunity.
Investors
considering opportunities in Life Sciences, including the CGT space
Acquirers
evaluating a Life Sciences or consulting business
Companies
considering a merger, acquisition or site purchase
Pharma & Biotech Owners
assessing strategic opportunities
Looking for an independent second opinion before making a significant decision? Contact us today.
What We Offer
Life Sciences Transactional Due Diligence
An independent assessment of a target business or opportunity across the areas that matter to the transaction.
Pharma Commercial Due Diligence
Market trends, competitive positioning, business performance, customer considerations and commercial viability to help test the opportunity.
Operational & Technical Due Diligence
Assessment of operations, engineering, manufacturing capability, project delivery, technical infrastructure and operational readiness.
Regulatory & Quality Review
Review of regulatory and quality considerations, including GMP, deviations, CAPAs, inspection readiness and potential compliance risks.
Financial & Performance Review
Analysis of financial health, business performance, project economics, cost pressures and other indicators that may affect the sustainability of the opportunity.
People & Organisation
Review of organisational structure, capability and attrition levels to help identify potential people-related risks or opportunities.
Look Deeper. Decide with Confidence
A strong headline is not enough. Before you invest, acquire or commit, you need to understand what sits underneath it.
Is the business performing as well as the numbers suggest?
Where are the operational weaknesses hiding?
Are recurring deviations and CAPAs pointing to a deeper issue?
Is the technical infrastructure capable of supporting future growth?
Are the market assumptions realistic or overly optimistic?
How dependent is the business on key people, customers or contracts?
What could put the investment, timeline or expected return at risk?
And perhaps most importantly, what questions haven’t been asked yet?
We bring together technical, operational, commercial and business insight to identify the issues that can influence value, performance and future growth.
Get in Touch
Make the next decision with your eyes open.
Talk to ZDx Global about your due diligence requirements.
